Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on October 30, 2007
JNCI Journal of the National Cancer Institute 2007 99(21):1574-1576; doi:10.1093/jnci/djm218
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/21/1574    most recent
djm218v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Twombly, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Twombly, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

NEWS

Childhood Cancer Survivor Study Doubles To Examine Late Effects of New Treatments

Renee Twombly

The first 150 words of the full text of this article appear below.

Children treated for cancer are living longer than ever and with a quality of life that is steadily improving, thanks in part to the long-running Childhood Cancer Survivor Study (CCSS). But oncologists are now concerned that the updated treatments that have resulted from CCSS research may carry a whole new set of risks and benefits not reflected in the original 20,000-plus childhood cancer survivors enrolled in CCSS.

That group includes children diagnosed with cancer between 1970 and 1986 and who survived at least 5 years, which means that all 72 CCSS publications and 52 study projects have been based on treatment given between 21 and 37 years ago.

Much has changed since then, which is why Les Robison, Ph.D., the researcher who created CCSS and who has championed it ever since, has been lobbying hard in recent years to expand CCSS to patients treated up through 1999. Finally, after 2 . . . [Full Text of this Article]

Health Issues Found in First Trial

Focus on Brain Tumors, Minorities


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?